Answers are grounded in this paper and cite their sources.
Preclinical study reveals enhanced antitumor immunity and immune memory in lung cancer models, highlighting the therapeutic potential of macrophage-reprogramming nanovaccines.
Plant-derived polysaccharides have been established as pivotal antitumor immune activators, demonstrating significant efficacy in tumor suppression and tumor immune microenvironment modulation. However, their clinical deployment has been substantially limited by weak stability and low absorption efficiency. In this study, we developed a nanovaccine coencapsulating a polysaccharide combination (GPS), formed by Astragalus polysaccharide (APS) and Ganoderma lucidum polysaccharide (GLP), within a mannose-modified PLGA framework, namely GPS@PLGA-man (GPM). By specifically targeting tumor-associated macrophages (TAMs), GPM effectively activates their tumor-killing and antigen-presenting capabilities, thereby establishing an immune-favorable niche for enhanced surveillance. The vaccine is constructed through the assembly of polysaccharide-based immune adjuvants, a PLGA backbone, and amine-polyethylene glycol-mannose conjugates, which function as both a TLR4 agonist and a macrophage-targeting ligand. This unique design enhances macrophage uptake, promotes TAM repolarization toward the M1 phenotype via the TLR4/MyD88/NF-κB pathway, and augments their tumoricidal activity. Moreover, hydrophobic interactions with PLGA facilitate the release of lung cancer cell antigens and promote tumor antigen adsorption, thereby optimizing macrophage-mediated antigen presentation and cytokine secretion, which in turn potentiates efficient T-cell priming. Essentially, GPM reshapes the tumor immune microenvironment and initiates an antitumor immune cascade. In combination with αPD-L1 therapy, GPM significantly promotes tumor regression and establishes long-term immune memory, highlighting its potential as an in situ antigen-capturing nanoimmunotherapy platform in preclinical lung cancer models.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: